A multifunctional -hybrid -composite material that incorporates carbon and glass fibres embedded into an epoxy matrix was developed. This material can be made to undergo a shape change without inserting activators. This is accomplished by selective heating of the embedded carbon fibres through the a
Development and testing of a human collagen graft material
✍ Scribed by Quteish, D. ;Singh, G. ;Dolby, A. E.
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 949 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
✦ Synopsis
Human Type I collagen was extracted from placenta using pepsin and salt fractionation. The collagen was characterized by SDS-PAG electrophoresis dispersed in acidic medium, freeze-dried, and crosslinked in an 0.25% glutaraldehyde solu- tion pH 4.5 for 2 days. After washing for 7 days and freeze drying the resultant collagen sponge was tested with regard to mechanical, physical, enzymatic degradation properties and biological responses. The modulus of elasticity was found to be 289 t 10 g/mm2 and the sponge was insoluble in water, buffered saline, or tissue culture medium over a period of 6 weeks with swelling occurring at less than 5% of volume. The sponge had a high fluid binding capacity, amounting to 56 ? 5 mL tissue culture medium per gram of dry weight. Bacterial collagenase produced slow degradation of the sponge with complete disappearance by 24 h only when high concentrations (200 units enzyme per mg of the collagen sponge) were used. Cytotoxicity studies using human gingival and periodontal ligament fibroblasts revealed less than 5% apparent cytotoxicity or proliferation. Subcutaneous implantation was followed by resorption and vascularization over a period of 6-8 weeks. It was concluded that the collagen sponge prepared from human Type I collagen has potential as a graft material in oral surgical procedures.
📜 SIMILAR VOLUMES
## Abstract Demineralized allogenic bone matrices (DABM) and demineralized freeze‐dried bone allograft (DFDBA) have been successfully used as bone‐graft materials in the treatment of acquired and congenital cranio–maxillofacial defects and in some orthopedic surgery. However, these bone‐graft “powd
A novel process of fusion bonding for the production of vascular grafts has been investigated. This process, based on the application of pressure and heat in a sophisticated way, has been used for the bonding of the longitudinal edges of flat dermal sheep collagen into tubular forms. The method prod
Animal-tissue-derived collagen, containing mostly type I collagen with a minor amount of type III collagen, has been widely used in the production of hemostats for many decades, although it has been known for a long time that type III collagen is more likely to induce platelet aggregation in vitro.
## Abstract Elastic salmon collagen (SC) vascular grafts were prepared by incubating a mixture of acidic SC solution and a fibrillogenesis‐inducing buffer containing a crosslinking agent [water‐soluble carbodiimide (WSC)] in a tubular mold at 4°C for 24 h and then at 60°C for 5 min. Subsequently, r